Evidence map›Paper›PMID 33847948›Full record

ArticleDrugs & aging2021

International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study.

Gülistan Bahat, Birkan Ilhan, Tugba Erdogan, Meryem Merve Oren, Mehmet Akif Karan, Heinrich Burkhardt, Michael Denkinger, Doron Garfinkel, Alfonso J Cruz-Jentoft, Yvonne Morrissey and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Drugs & aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 8 countries.

Gülistan BahatDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey. gbahatozturk@yahoo.com.ORCID 0000-0001-6039-5866
Birkan IlhanDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey.
Tugba ErdoganDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey.
Meryem Merve OrenDepartment of Public Health, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey.
Mehmet Akif KaranDivision of Geriatrics, Department of Internal Medicine, Istanbul Medical School, Istanbul University, Capa, 34390, Istanbul, Turkey.
Heinrich BurkhardtIVth Medical Department, Medical Faculty Mannheim, University Medical Center, Heidelberg University, Mannheim, Germany.
Michael DenkingerGeriatric Center Ulm/Alb-Donau, Agaplesion Bethesda Ulm, Geriatric Research Ulm University, Ulm, Germany.
Doron GarfinkelCenter for Appropriate Medication Use, Sheba Medical Center and Deputy Head, Homecare Hospice, Israel Cancer Association, 55 Ben Gurion Road, Bat, 5932210, Yam, Israel.
Alfonso J Cruz-JentoftServicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Yvonne MorrisseyEast Kent Hospitals University NHS Foundation Trust, Ethelbert Road, Canterbury, Kent, CT1 3NG, UK.
Graziano OnderDepartment of Cardiovascular, Endocrine-metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
Farhad PazanMedical Faculty Mannheim, Institute of Clinical Pharmacology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
Eline TommeleinDepartment Pharmaceutical Sciences (FARM)-Laboratory Pharmaceutical Chemistry, Drug Analysis and Drug Information (FASC), Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Jette, Belgium.
Eva TopinkovaDepartment of Geriatrics, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Nathalie van der VeldeDepartment of Internal Medicine, Geriatrics, Amsterdam Public Health Research Institute, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Mirko PetrovicSection of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Istanbul University · TRHeidelberg University · DEAgaplesion Bethesda Klinik · DECharles University · CZEast Kent Hospitals University NHS Foundation Trust · GBGhent University Hospital · BEInstituto Ramón y Cajal de Investigación Sanitaria · ESIstituto Superiore di Sanità · ITSheba Medical Center · ILVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveExplicit screening tools and implicit evaluation methods have been developed to assist healthcare professionals in the management of pharmacotherapy in older adults. As prescribing habits and locally available medications vary considerably between countries, guides tailored to the needs of specific regions may be required. We aimed to report the results of the international Delphi validation study for the Turkish Inappropriate Medication use in the Elderly (TIME) criteria set, which aims to detect inappropriate prescribing in older adults in Eastern Europe.

methodsThe study was conducted between June 2019 and March 2020. Delphi rounds were conducted by the TIME international working group, which included 11 internationally recognized experts in geriatric pharmacotherapy as Delphi panelists. They were asked to indicate to what extent they agreed or disagreed with each TIME criterion, taking into account both the available evidence and their own experience. We used a five-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) and an online software program (SurveyMonkey

resultsAfter three Delphi rounds, 134 criteria were accepted and seven criteria were rejected, while 12 criteria did not achieve consensus, and so were not included in the final validated set of TIME criteria.

conclusionWe developed the internationally validated TIME criteria set based on a Delphi process involving international experts. The validation study suggests that the TIME criteria set can be applied in both central and Eastern European settings. Further studies are needed to assess the utility and benefit of the TIME criteria in reducing inappropriate drug use and improving clinical outcomes.

Indexed as

Inappropriate PrescribingAgedConsensusDelphi TechniqueHumans

Identifiers

PMID33847948
PMCPMC8041618
OpenAlexW3153823416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.